DHI GROUP, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DHI GROUP, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	227	208	162	149	137	120	150	152	142	128
Cost of revenue	32.1	30	18.3	13.5	14.3	15.1	17.6	19.8	20.2	19.6
Gross profit	195	178	143	136	123	105	132	132	122	108
Research and development	25.7	25	20.2	14.7	14.9	16	17.7	17.8	18.9	12.8
Selling and marketing	77.5	80.5	59.7	42.7	39.7	43.7	59.4	57.4	47.4	39.8
General and administrative	43.7	40.7	37.6	25.8	26.6	28.6	34	31.3	30	27.1
Operating expenses			153
Operating income	3.39	22.9	11.7	10.1	-32.4	-1.75	5.56	6.29	6.33	-11.4
Interest expense	3.48	3.45	2.05	0.7	0.83	0.67	1.58	3.48	3.2	2.46
Other non-operating income	-0.03	-0.02	-0.04	0	0
Pre-tax income	-0.12	19.4	9.6	9.43	-35.2	-1.03	3.6	3.62	2.95	-14.7
Income tax	5.28	3.42	2.43	2.79	-2.83	-0.63	-0.58	0.13	2.7	-1.18
Income from continuing operations				6.63	-32.4	-0.4	4.18	3.49
Net income	-5.4	16	7.17	12.6	-30	-29.7	4.18	3.49	0.25	-13.5
EBITDA	13.2	32.6	21	19.9	-20.4	15.4	23	23.2	24.3	2.87
EPS, basic	-0.11	0.33	0.15	0.26	-0.62	-0.64	0.09	0.08	0.01	-0.30
EPS, diluted	-0.11	0.33	0.14	0.24	-0.62	-0.64	0.09	0.08	0.01	-0.30
Shares, basic (weighted)	48.3	47.9	48.5	48.7	48.3	46.3	44.3	43.6	44.6	44.8
Shares, diluted (weighted)	48.3	48.2	49.6	51.6	48.3	46.3	46.5	44.5	45.1	44.8

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	23	12.1	6.47	5.38	4.54	1.54	3.01	4.21	3.7	2.91
Receivables	43.1	38.8	22.9	21.2	16.1	18.4	20.5	22.2	22.1	18
Other current assets	3.31	5.09	7.33	4.18	4.1	4.18	4.29	4.24	3.59	3.46
Total current assets	70.2	58.5	38.9	33.1	33.5	24.5	27.8	30.9	29.7	24.5
Property, plant and equipment	16.6	16.1	15.9	20.4	23	20.6	21.3	25.3	20.4	13.3
Lease right-of-use assets			0	19.7	10.8	6.89	6.58	4.76	6.52	4.37
Goodwill	172	171	154	156	128	128	128	128	128	121
Intangible assets	49.1	45.7	39	39	23.8	23.8	23.8	23.8	23.8	15.5
Other non-current assets	2.14	4.03	2.59	2.6	1.38	1.85	3.85	4.1	3.62	2.58
Total assets	310	296	258	278	241	222	227	225	221	188
Accounts payable	20.2	22.2	25	18.9	15.3	15.9	23.8	17.4	16.2	13.6
Deferred revenue	84.6	83.6	54.7	50.6	35.5	45.2	50.1	49.5	44.9	39.7
Total current liabilities	108	107	80.9	74.1	65.4	63.5	74.1	68.9	62.7	55.1
Long-term debt	84.8	41.5	17.3	9.44	19.6	22.7	30	38	32	30
Lease liabilities			0	16.7	9.37	6.98	8.43	6.54	9	7.39
Other non-current liabilities	2.74	2.06	1.33	1.26	2.05	1.01	0.93	0.49	0.39	0.3
Total liabilities	206	163	113	117	113	105	120	118	107	93.7
Total debt	84.8	41.5	17.3	9.44	19.6	22.7	30	38	32	30
Paid-in capital	366	376	383	227	234	242	252	262	270	130
Retained earnings	44.1	59.8	71.4	84	54	24.2	28.4	32.2	32.5	19
Treasury stock	-275	-276	-279	-121	-132	-150	-174	-187	-189	-55.4
Other comprehensive income	-32.3	-27.3	-31.2	-29.2	-28.5	-0.06	-0.48	-0.08	0	-0.01
Shareholders' equity	104	133	145	161	128	116	106	108	114	94.5
Total equity	104	133	145	161	128	116	106	108	114	94.5
Total liabilities and equity	310	296	258	278	241	222	227	225	221	188
Shares outstanding	49.6	50.5	53.4	53.9	51.2	48.8	47.4	46.9	48.2	44.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-5.4	16	7.17	12.6	-30	-29.7	4.18	3.49	0.25	-13.5
Depreciation and amortization	9.85	9.75	9.28	9.74	12	17.1	17.5	16.9	18	14.2
Stock-based compensation	11.1	8.61	6.6	5.7	6.3	8.3	9.5	9.9	8.1	4.9
Deferred income tax	-2.96	0.22	2.28	2.2	-2.49	-0.45	-3.8	-3.3	-0.85	-1.25
Change in receivables	2.28	1.98	11.9	1.69	0.86	-1.1	-2.11	-1.4	0.11	4.16
Change in payables	-2.95	1.66	1.74	-5.62	0.14	-1.52	7.78	-7.09	-0.41	-2.86
Cash from operations	45	34.4	14.9	22.9	18.7	28.6	36	21.3	21	21.1
Capital expenditures	-11.7	-13.2	-10.1	-14.2	-16.1	-14.3	-18	-20.3	-13.9	-7.31
Acquisitions	0							0	0	-1.4
Cash from investing	-10.8	-0.78	7.49	-11.5	-15.9	-19.3	-17.7	-15.3	-13.9	-8.71
Debt issued	27	0	7	20	36.4	14	18	33	17	6
Debt repaid	-42	-44	-31	-28	-26.4	-11	-11	-25	-23	-8
Stock issued	2.81	0.4	0	0	0	0	0.29	0.3	0.26	0.14
Share buybacks	-29.6	0	-1.98	-2.52	-8.29	-15.4	-18.5	-6.9	0	-9.66
Cash from financing	-44.6	-44.8	-27.2	-12.4	-0.54	-15.4	-16.9	-4.83	-7.62	-13.2
Exchange rate effect	-0.66	0.23	-0.83	-0.09	0.02	0.01	0	0
Net change in cash	-11.1	-10.9	-5.6	-1.09	2.26	-6.1	1.47	1.2	-0.5	-0.79
Free cash flow	33.3	21.2	4.87	8.74	2.58	14.3	18.1	1.09	7.11	13.8
Interest paid	3.26	3.25	1.81	0.64	1.1	0.83	1.48	3.47	3.18	2.45
Income taxes paid	9.1	4.7	2.63	1.51	0.46	0.39	2.85	3.45	3.53	0.48

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.73 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	4.9%	Operating income / revenue.
EBITDA margin	14.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	2.2%	Pre-tax income / revenue.
Net margin	1.0%	Net income / revenue.
FCF margin	16.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	21.3%	Cash from operations / revenue.
Effective tax rate	55.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	1.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.6%	Net income / average total assets.
Return on invested capital (ROIC)	3.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	9.5%	Research and development expense / revenue.
Capex / revenue	5.1%	Capital expenditures / revenue.
D&A / revenue	9.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-9.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-5.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-11.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-6.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-279.8%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-88.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-50.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-5,440.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-3,100.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	0.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-16.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	2.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	93.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-8.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	39.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-17.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-3.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-5.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-6.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.44x	Current assets / current liabilities.
Quick ratio	0.38x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.07x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.34x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	17.0%	Total debt / total assets.
Liabilities / assets	50.1%	Total liabilities / total assets.
Net debt	$28.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.59x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.50x	Operating income / interest expense.
Working capital	-$29.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	74.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$45.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.66x	Revenue / average total assets.
Fixed asset turnover	10.9x	Revenue / average property, plant and equipment.
Receivables turnover	7.53x	Revenue / average receivables.
Days sales outstanding	48 days	365 x average receivables / revenue.
FCF conversion	1,661.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	24.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.96	Revenue / diluted weighted shares.
FCF per share	$0.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.63	Cash from operations / diluted weighted shares.
Book value per share	$2.18	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.06	Tangible book value / shares outstanding.
Cash per share	$0.09	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	64.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$205.4M	Share price x shares outstanding.
Enterprise value	$233.6M	Market cap + total debt - cash - short-term investments.
P/E	170x	Market cap / net income. Only when net income is positive.
P/S	1.65x	Market cap / revenue.
P/B	2.18x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	10.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.75x	Market cap / cash from operations, when positive.
EV/Sales	1.88x	Enterprise value / revenue.
EV/EBIT	38.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	11.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.8%	Free cash flow / market cap.
Earnings yield	0.6%	Net income / market cap (the inverse of P/E).
Shareholder yield	6.3%	(Dividends paid + share buybacks) / market cap.

What was DHI GROUP, INC.'s revenue in fiscal 2025?

DHI GROUP, INC. reported revenue of $127.8M for fiscal 2025, 9.9% lower than the year before.

Was DHI GROUP, INC. profitable in fiscal 2025?

No. It reported a net loss of $13.5M.

How much free cash flow did DHI GROUP, INC. generate in fiscal 2025?

Cash from operations of $21.1M minus capital expenditures of $7.3M left free cash flow of $13.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DHI GROUP, INC.